Gandilhon P, Melançon R, Gandilhon F, Djiane J, Kelly P A
Anticancer Res. 1983 May-Jun;3(3):203-6.
Mammary tumors were induced by N-nitrosomethylurea (NMU) in young female Sprague-Dawley rats and time of appearance of the tumors was recorded daily. A total of 41 tumors of different ages (7 to 110 days old) were removed and prolactin (PRL) receptors were measured using [125I] human growth hormone (hGH) (equipotent lactogenic activity to oPRL). All but one tumor contained high PRL receptor levels. However, there was a slight decline of both free and total PRL receptor levels with increasing tumor age, with total prolactin receptor levels in tumors 7-20 days old being 32.0 +/- 1.4% compared to 26.0 +/- 2.0% in tumors 66-110 days old (p less than 0.05). In addition, for 24 of these tumors which were of sufficient size, explant cultures were carried out up to 24 h in medium-199 containing insulin and cortisol in the presence or absence of 20 microgram/ml oPRL. At this concentration, an occupation of free and a reduction of total receptor levels was observed in all explant cultures. This down-regulation also appeared to vary as a function of tumor age. Total PRL receptors declined 24.9 +/- 2.3% in young tumors (7-35 days old) compared to 41.7 +/- 4.4% in tumors 50-110 days old (p less than 0.01). The present data are important in that they demonstrate that PRL receptor levels are relatively high regardless of the age of the tumor with, however, a slight decline with increased tumor age. In contrast, the responsiveness of the tumors measured by the ability of prolactin to down-regulate its own receptors is greater in older tumors.
用N-亚硝基甲基脲(NMU)诱导年轻雌性斯普拉格-道利大鼠发生乳腺肿瘤,并每日记录肿瘤出现的时间。共切除41个不同年龄(7至110天)的肿瘤,使用[125I]人生长激素(hGH)(与oPRL具有同等生乳活性)测量催乳素(PRL)受体。除一个肿瘤外,所有肿瘤的PRL受体水平都很高。然而,随着肿瘤年龄的增加,游离和总PRL受体水平均略有下降,7至20天龄肿瘤的总催乳素受体水平为32.0 +/- 1.4%,而66至110天龄肿瘤为26.0 +/- 2.0%(p<0.05)。此外,对于其中24个足够大的肿瘤,在含有胰岛素和皮质醇的199培养基中进行外植体培养,培养24小时,培养基中添加或不添加20微克/毫升oPRL。在此浓度下,在所有外植体培养物中均观察到游离受体的占据和总受体水平的降低。这种下调似乎也随肿瘤年龄而变化。年轻肿瘤(7至35天龄)的总PRL受体下降24.9 +/- 2.3%,而50至110天龄肿瘤下降41.7 +/- 4.4%(p<0.01)。目前的数据很重要,因为它们表明,无论肿瘤年龄如何,PRL受体水平相对较高,但随着肿瘤年龄的增加会略有下降。相比之下,通过催乳素下调其自身受体的能力来衡量,老年肿瘤的肿瘤反应性更大。